Takehiro Yasukawa

Years Active: 2018-2024
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Yasuhiro Nakamura, Takehiro Yasukawa, Yuki Fukumura, Yoshinori Takeda, Hiroshi Imamura, Yang Shi, Mu Li, Masaaki Abe, Saya Uyama, Kazunori Kajino, Muneaki Ishijima, Akio Saiura, Akira Orimo
Association of stromal type IV collagen and prognosis in neoadjuvant chemotherapy-treated pancreatic cancer. Japanese journal of clinical oncology (2024)
Yu Koyama, Hiroya Okazaki, Yang Shi, Yoshihiro Mezawa, Zixu Wang, Mizuki Sakimoto, Akane Ishizuka, Yasuhiko Ito, Takumi Koyama, Yataro Daigo, Atsushi Takano, Yohei Miyagi, Tomoyuki Yokose, Toshinari Yamashita, Keisuke Sugahara, Okio Hino, Liying Yang, Reo Maruyama, Akira Katakura, Takehiro Yasukawa, Akira Orimo
Increased RUNX3 expression mediates tumor-promoting ability of human breast cancer-associated fibroblasts. Cancer medicine (2023)
Haruna Tani, Kaori Ishikawa, Hiroaki Tamashiro, Emi Ogasawara, Takehiro Yasukawa, Shigeru Matsuda, Akinori Shimizu, Dongchon Kang, Jun-Ichi Hayashi, Fan-Yan Wei, Kazuto Nakada
Aberrant RNA processing contributes to the pathogenesis of mitochondrial diseases in trans-mitochondrial mouse model carrying mitochondrial tRNALeu(UUR) with a pathogenic A2748G mutation. Nucleic acids research 50 (16) (2022)
Shigeru Matsuda, Takehiro Yasukawa, Yuriko Sakaguchi, Kenji Ichiyanagi, Motoko Unoki, Kazuhito Gotoh, Kei Fukuda, Hiroyuki Sasaki, Tsutomu Suzuki, Dongchon Kang
Accurate estimation of 5-methylcytosine in mammalian mitochondrial DNA. Scientific reports 8 (1) (2018)

Takehiro Yasukawa.css-eqlu8i{font-size:small;padding-left:4px;}